|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.39 USD | +9.63% |
|
+22.56% | +18.91% |
| Apr. 15 | Top Premarket Decliners | MT |
| Jan. 30 | Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023 | CI |
Universe Pharmaceuticals INC reported earnings results for the half year ended March 31, 2023. For the half year, the company reported sales was USD 18.47 million compared to USD 24.2 million a year ago. Net loss was USD 0.715427 million compared to net income of USD 1.73 million a year ago.
Basic loss per share from continuing operations was USD 0.2 compared to basic earnings per share from continuing operations of USD 0.48 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +18.91% | 8.66M | |
| +37.08% | 6.01B | |
| -17.43% | 4.4B | |
| -9.46% | 3.17B | |
| +0.51% | 3.07B | |
| -3.53% | 2.51B | |
| +41.15% | 1.88B | |
| -5.15% | 1.73B | |
| +0.09% | 1.65B | |
| -10.38% | 1.58B |
UNIVERSE PHARMACEUTICALS INC 
